Dolby Laboratories (DLB) Cash from Investing Activities Growth (1y) (2016 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Relx |
81.40 Bn |
81.16 Bn |
- |
- |
| 2 |
Rentokil Initial |
79.56 Bn |
78.10 Bn |
- |
- |
| 3 |
Cintas |
69.26 Bn |
69.08 Bn |
1.45 Bn |
19.38% |
| 4 |
Copart |
33.09 Bn |
28.01 Bn |
971.24 Mn |
89.96% |
| 5 |
UL Solutions |
20.56 Bn |
20.32 Bn |
381.00 Mn |
-22.00% |
| 6 |
Global Payments |
19.88 Bn |
14.69 Bn |
1.70 Bn |
3,402.45% |
| 7 |
Rb Global |
19.08 Bn |
18.89 Bn |
869.50 Mn |
22.67% |
| 8 |
Aramark |
13.57 Bn |
13.16 Bn |
426.35 Mn |
35.30% |
| 9 |
Amentum Holdings |
5.65 Bn |
5.74 Bn |
345.00 Mn |
- |
| 10 |
Dolby Laboratories |
5.15 Bn |
4.56 Bn |
350.90 Mn |
-277.98% |
| Date | Value |
| Mar 27, 2026 |
-277.98% |
| Dec 26, 2025 |
115.29% |
| Sep 26, 2025 |
91.61% |
| Jun 27, 2025 |
16.99% |
| Mar 28, 2025 |
244.88% |
| Dec 27, 2024 |
-1,386.10% |
| Sep 27, 2024 |
-1,225.70% |
| Jun 28, 2024 |
-135.15% |
| Mar 29, 2024 |
-175.78% |
| Dec 29, 2023 |
-97.76% |
| Sep 29, 2023 |
51.60% |
| Jun 30, 2023 |
369.95% |
| Mar 31, 2023 |
119.50% |
| Dec 30, 2022 |
122.44% |
| Sep 30, 2022 |
-172.26% |
| Jul 1, 2022 |
42.49% |
| Apr 1, 2022 |
-748.23% |
| Dec 31, 2021 |
-8,313.01% |
| Sep 24, 2021 |
-109.67% |
| Jun 25, 2021 |
-152.66% |
| Mar 26, 2021 |
-45.47% |
| Dec 25, 2020 |
95.99% |
| Sep 25, 2020 |
804.72% |
| Jun 26, 2020 |
373.10% |
| Mar 27, 2020 |
55.22% |
| Dec 27, 2019 |
10.01% |
| Sep 27, 2019 |
-54.44% |
| Jun 28, 2019 |
-122.10% |
| Mar 29, 2019 |
-195.09% |
| Dec 28, 2018 |
-53.42% |
| Sep 28, 2018 |
239.49% |
| Jun 29, 2018 |
170.87% |
| Mar 30, 2018 |
155.49% |
| Dec 29, 2017 |
-1.65% |
| Sep 29, 2017 |
82.76% |
| Jun 30, 2017 |
-14.40% |
| Mar 31, 2017 |
-584.65% |
| Dec 30, 2016 |
66.66% |
| Sep 30, 2016 |
-405.37% |
| Jul 1, 2016 |
32.52% |